Assembly Biosciences (ASMB) Income from Continuing Operations: 2009-2024
Historic Income from Continuing Operations for Assembly Biosciences (ASMB) over the last 14 years, with Dec 2024 value amounting to -$40.2 million.
- Assembly Biosciences' Income from Continuing Operations rose 4.34% to -$9.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$37.2 million, marking a year-over-year increase of 4.03%. This contributed to the annual value of -$40.2 million for FY2024, which is 34.38% up from last year.
- As of FY2024, Assembly Biosciences' Income from Continuing Operations stood at -$40.2 million, which was up 34.38% from -$61.2 million recorded in FY2023.
- Over the past 5 years, Assembly Biosciences' Income from Continuing Operations peaked at -$40.2 million during FY2024, and registered a low of -$129.9 million during FY2021.
- For the 3-year period, Assembly Biosciences' Income from Continuing Operations averaged around -$64.8 million, with its median value being -$61.2 million (2023).
- In the last 5 years, Assembly Biosciences' Income from Continuing Operations spiked by 36.34% in 2020 and then tumbled by 108.93% in 2021.
- Yearly analysis of 5 years shows Assembly Biosciences' Income from Continuing Operations stood at -$62.2 million in 2020, then crashed by 108.93% to -$129.9 million in 2021, then increased by 28.31% to -$93.1 million in 2022, then skyrocketed by 34.23% to -$61.2 million in 2023, then soared by 34.38% to -$40.2 million in 2024.